Retinal Vessel Analysis (rGA) at the Patient Bed in the Context of Non-traumatic Subarachnoid Haemorrhage
Launched by RWTH AACHEN UNIVERSITY · Sep 17, 2019
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Female or male patient, age ≥ 18 years
- • Inpatient stay in the clinic
- • Written informed consent for participation in the study prior to beginning of treatment
- • Written consent for further evaluation of the images and for the scientific publication of the study results
- • Non-traumatic subarachnoid haemorrhage confirmed by computer tomography or magnetic resonance tomography or cerebrospinal fluid puncture (collection of nerve water from the lower part of the lumbar spine
- Exclusion Criteria:
- • Female or male patient \< 18 years
- • Pregnancy, Lactation
- • Lack of written consent to participate in the study and to further evaluate the image material collected
- • Known allergy to MS eye drops (active substance: phenylephrine/tropicamide
- • Narrow chamber angle, narrow angle glaucoma, Terson syndrome (if it makes retinal vascular imaging impossible
- • Persons in a dependency or employment relationship with the investigator
- • Persons who are accommodated in a facility by judicial or administrative order
- • Receipt and intake of a study drug within the last 30 days
- • Supine position in bed
About Rwth Aachen University
RWTH Aachen University is a prestigious research institution located in Aachen, Germany, renowned for its commitment to advancing science and technology through innovative research and education. As a clinical trial sponsor, RWTH Aachen University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research aimed at improving patient outcomes. The university collaborates with various healthcare stakeholders to facilitate the translation of scientific discoveries into effective therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements throughout the research process. With a focus on fostering knowledge exchange and driving clinical advancements, RWTH Aachen University plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aachen, , Germany
Patients applied
Trial Officials
Gerrit A Schubert, Prof. Dr.
Principal Investigator
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials